Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
13,953
12,313
18,551
18,195
26,660
Cash flow Operating Act...
Cash flow Operating Activities
11,4937,7599,54312,15919,469
Investments in PPE
Investments in PPE
-3,767-2,739-7,331-11,832-9,102
Cash flow Investing Act...
Net cash used for Investment Activities
-11,372-4,783-6,854-835751
Dividend Paid
Dividend Paid
03,1923,20010,2410
Cash flow Financing Act...
Net cash provided by Financing Activities
-93-3,142-2,459-10,914-349
Cash at beginning of period
Cash at beginning of period
179-43-20921432
Cash at end of period
Cash at end of period
208-2092143220,303
Free Cash Flow
Free Cash Flow
7,726
5,020
2,212
327
10,367